First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers.

Name: First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers.
Author: Sikic, Branimir I

First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers. — المؤلف: Sikic, Branimir I — Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20200402

المؤلف: Sikic, Branimir I
النشر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20200402
الوصف: 946-953 p.
الموضوعات: Adult؛ Aged؛ Aged, 80 and over؛ Antibodies, Monoclonal, Humanized؛ Antineoplastic Agents, Immunological؛ Biopsy؛ CD47 Antigen؛ Cohort Studies